Flash Therapeutics specializes in the development of gene and cell-based therapies using its proprietary lentiviral vector platform, which enables stable and long-term DNA transfer. The company provides reliable viral vector manufacturing services to meet the growing demand for effective treatments in cell and gene therapy.
Funding
$17.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
TCFounders
Product
Problem
The cell and gene therapy field faces challenges in achieving stable and efficient gene delivery, often relying on viral vectors that may have limitations in terms of safety, payload capacity, or production scalability. Meeting the increasing demand for effective viral vector manufacturing requires reliable and flexible solutions for both research and clinical applications.
Solution
Flash BioSolutions is a contract development and manufacturing organization (CDMO) specializing in viral vector technologies for gene and cell therapies, offering both research-grade and GMP-grade manufacturing services. The company leverages its expertise in lentiviral vectors (LentiCare®) and RNA delivery (FlashRNA®) to provide customized solutions for stable or transient gene expression. Flash BioSolutions supports clients through process development, scale-up, and GMP manufacturing, utilizing its state-of-the-art facility with multiple GMP-certified viral vector production suites. In addition to its established platforms, Flash BioSolutions offers process development for other vector production, providing tailored methodologies to meet unique client needs in vaccine development, oncolytic viruses, and exosome manufacturing.
Target Audience
The primary target audience includes biotech and pharmaceutical companies, research institutions, and clinical organizations involved in cell and gene therapy development, vaccine production, and related fields seeking reliable viral vector manufacturing and process development services.
Features
- LentiCare®: Third-generation lentiviral vector platform for stable and long-term DNA transfer with high transduction efficiency in various cell types.
- FlashRNA®: Innovative RNA vector technology for fast and transient expression, suitable for cell reprogramming, gene editing (CRISPR-Cas9), and vaccine development.
- GMP Manufacturing: Manufacturing services for clinical and commercial batches, adhering to EU and US regulatory requirements for Starting Materials and Drug Products.
- Custom Vector Production: Tailored solutions for a diverse range of viral vector therapies, including process development, scale-up, and GMP manufacturing.
- Analytical Method Development: Thorough gap analysis of client processes and analytical methods to define precise scale-up strategies and validate necessary adjustments.
- Fill & Finish Services: Dedicated fill & finish suite meeting EU and US regulatory requirements.